FDA approves capivasertib with fulvestrant for breast cancer
Mary Beth Nierengarten
Topics & Concepts
FulvestrantMedicineBreast cancerCancerOncologyInternal medicineTamoxifenAdvanced Breast Cancer TherapiesCancer-related Molecular PathwaysBreast Cancer Treatment Studies